Pimple

Global Skin Toner Market Analysis Report, 2023-2024 and 2029 - Surging Trend of Diversity and Inclusivity and Accelerating Popularity of Online Shopping and E-Commerce Platforms - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Cosmetics, Online Retail, Retail, Skin care, Nicotinamide, COVID-19, Pimple, Research, Female, Dermatology, Woman, Supermarket, Acne, Skin, Mist, Habit, Market, Salicylic acid

The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.

Key Points: 
  • The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.
  • The global skin toners market is extremely competitive and consists of various global and regional players.
  • Looking ahead, the skin toners market is expected to continue its growth trajectory for several reasons.
  • One notable aspect of the skin toners market is the growing awareness regarding skincare and protection among the millennial population, across the world, in the recent years.

Galderma Announces Record 2023 Net Sales of Over 4 B USD and Significant Core EBITDA Margin Expansion

Retrieved on: 
Thursday, February 29, 2024
Research, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Cosmetics, Retail, Science, Other Science, Adapalene, Education, Investment, Growth, Calcineurin, Skin, Database, STAR, FY, Aesthetics, Acne, Sculptra, Prurigo nodularis, Defense, FACE, European Medicines Agency, Council, Congress, Pimple, GAIN, Atopic dermatitis, Sleep, ESG, Benzoyl peroxide, George Washington University, American Academy, Marketing, Health Canada, Core, Patient satisfaction, FDA, Quality of life, Ageing, Food, IL-31, Risk, AAD, Patient, Restylane, Pharmaceutical industry

2023 margin expansion was driven by gains from premiumization, structural cost savings, and operating expenses leverage, partially offset by nemolizumab investments.

Key Points: 
  • 2023 margin expansion was driven by gains from premiumization, structural cost savings, and operating expenses leverage, partially offset by nemolizumab investments.
  • On 26 June 2023, Galderma announced a private placement of approximately 1 B USD from a group consisting of current shareholders, new investors, as well as management.
  • Cetaphil, with over 75 years of heritage in sensitive skincare, surpassed a record 1 B USD in net sales in 2023.
  • In 2023, Galderma further consolidated its ESG profile by rolling out a dedicated executive-level ESG oversight and instituting the ESG Council.

JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval

Retrieved on: 
Tuesday, March 5, 2024
Senior, Tenderness, Infection, Dizziness, AbbVie, XC, Lidocaine, Swelling, Exercise, Skin, Pregnancy, History, Cyst, Red, HIV/AIDS, Trial of the century, Allergy, Social media, Incidence, Neck, Dermatology, Aspirin, Pain, Forehead, Stroke, Hyaluronic acid, Pimple, Pigment, Ibuprofen, Scar, Rash, Anaphylaxis, Chin, Learning, Weakness, Safety, Filler (linguistics), DSM-IV codes, Hypoesthesia, Clinical trial, Paratriathlon, Bleeding, Face, Jaw, ABBV, Injection, Bruise, AMI, Inflammation, FDA, TSR, U.S. FDA, Confusion, Risk, Steroid, Patient, Tell, Wound, Gram, HIV, Cheek

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.1 JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) dermal filler to receive U.S. FDA approval for the improvement of moderate to severe temple hollowing with results lasting up to 13 months with optimal treatment.*1

Key Points: 
  • *1
    "The approval of JUVÉDERM® VOLUMA® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie.
  • "This is the first U.S. FDA approval of a hyaluronic acid dermal filler for use in the upper face and addresses a real unmet need for patients."
  • The safety of JUVÉDERM® VOLUMA® XC in patients with a history of excessive scarring or pigmentation disorders has not been studied.
  • To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1‑877‑345‑5372.

ZitSticka Announces Nationwide Retail Expansion Into CVS Pharmacy

Retrieved on: 
Wednesday, February 28, 2024
Pimple, Acne, Nose, Skin, GOO, SPF, Pharmacy, CVS Pharmacy, CVS, Salicylic acid, UVB, Cosmetics

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- ZitSticka, the science-based skincare brand specializing in effective acne-fighting technology to provide clear skin and acne-free solutions, announces today its expansion into CVS Pharmacy stores nationwide and online at www.cvs.com. Available in the skincare aisle, consumers can now select from eight ZitSticka products, including two CVS exclusives, the GOO GETTER™ Nose and the recently launched Slugging Balm, along with for the first time in brick-and-mortar, the KILLA™ ACNE Extra Strength Patches.

Key Points: 
  • NEW YORK, Feb. 28, 2024 /PRNewswire/ -- ZitSticka , the science-based skincare brand specializing in effective acne-fighting technology to provide clear skin and acne-free solutions, announces today its expansion into CVS Pharmacy stores nationwide and online at www.cvs.com .
  • "We are excited to join CVS Pharmacy in helping provide added accessibility to consumers who are looking to drugstores for skin care solutions," said Trish Kozlak, Head of Retail at Heyday.
  • "Offering a range of innovative skincare products from pre-pimple to post-pimple care, this expansion will help us provide customers effective acne solutions at their local CVS store."
  • To learn more about ZitSticka and its offerings, visit zitsticka.com or follow along on Instagram @zitsticka and TikTok @zitsticka .

Herbal medicinal product: Echinaceae purpureae radixArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024
Pimple, Allergy, Committee, Acne, Asteraceae, Plant, Date, Echinacea, Mouth, Patient, Medicine, Herbal medicine, Water, Ethanol

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of purple coneflower root.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing purple coneflower root.
  • Purple coneflower root preparations may also be found in combination with other herbal substances in some herbal medicines.
  • Key facts
    - Latin name
    - Echinaceae purpureae radix
    - English common name
    - Purple Coneflower Root
    - Botanical name
    Echinacea purpurea (L.) Moench.

Perfect Corp. Expands AI Skin Simulation Technology, Helping Consumers Visualize Skin Improvements in Seconds

Retrieved on: 
Thursday, February 1, 2024
Software, Men, Mobile, Wireless, Luxury, Consumer, Apps, Applications, Technology, Artificial Intelligence, Fashion, Teens, Cosmetics, Retail, Women, Multimedia, Red, AI, Pimple, Skin, Total, Corp, Acne

With the newest addition of acne, oiliness and radiance skin simulation technology, the expanded AI skin simulation solution will now provide skin improvement simulations for 10 unique skin metrics.

Key Points: 
  • With the newest addition of acne, oiliness and radiance skin simulation technology, the expanded AI skin simulation solution will now provide skin improvement simulations for 10 unique skin metrics.
  • Expands AI Skin Simulation Technology, Helping Consumers Visualize Skin Improvements in Seconds (Photo: Business Wire)
    Expanding the Capabilities of Skin Simulation Technology to Visualize Progressive Skin Improvements to a Total of 10 Unique Skin Metrics.
  • Introducing advanced skin simulation features, the latest innovation expands the scope of visualizing progressive skin improvements to a total of 10 unique skin metrics.
  • To learn more about Perfect Corp.’s AI Skin Simulation technology, click here: https://www.perfectcorp.com/business/products/ai-skin-emulation
    To learn more about Perfect Corp.’s AI Skin Analysis technology, click here: https://www.perfectcorp.com/business/products/ai-skin-diagnostic

Peace Out Skincare Expands Patented Acne Dot Line with Breakthrough Innovation

Retrieved on: 
Wednesday, December 13, 2023
Dark, Blemish, Absorption, Salicylic acid, Gen, Gland, Life, Head, Hyperpigmentation, Generation Alpha, LOS, Inflammation, Pimple, Generation Z, Skin, Cosmetics, Sephora, Acne

LOS ANGELES, Dec. 13, 2023 /PRNewswire/ -- Peace Out Skincare, the creators of the viral pimple patch movement, has once again revolutionized the approach to pimple care with the addition of their new Early Stage Acne Dot to its portfolio. This one-step targeted treatment is uniquely suited to attack blemishes residing below-the-surface and help minimize pimples before they come to a head.

Key Points: 
  • With over 75 millions Dots sold to date, Peace Out Skincare has captured an oversaturated market with their unparalleled offering of being the only brand with a patented, clean, and over-the-counter medicated pimple patch.
  • As The Experts in Acne Prone Skin, Peace Out Skincare is uniquely suited to cater to the needs of the growing Gen Z and Gen Alpha consumers by providing simple solutions to their chief skincare concern.
  • "At Peace Out Skincare our mission is to create an all-encompassing collection of innovative, first-to-market, targeted products and routines for your skin's lifetime journey.
  • The Early Stage Acne Dot is Peace Out Skincare's latest innovation in their pursuit of fun, easy-to-use and simple skincare solutions that leave you feeling confident to live-life unfiltered.

Sun Pharma Survey Reveals Americans with Mild-to-Moderate Acne Have Defeatist Attitudes About Treatment, Despite Self-Consciousness

Retrieved on: 
Thursday, November 2, 2023
FAAD, Knowledge, Union of Sales and Marketing Professionals, DO, Social media, Dermatology, Family, Hope, Skin care, Medical director, Skin, Doctor of Philosophy, Inflammation, Friends, Pimple, Acne, Androgen, Sun Pharma, Breakout, Hormone, Schizoid avoidant behavior, MMS, Marketing, Gland, Cosmetics, Birth control, Online shopping, MD

Among the 1,003 survey respondents ages 13-55, only three in 10 reported having seen a dermatologist, suggesting that many people with mild-to-moderate acne are missing out on effective treatments.

Key Points: 
  • Among the 1,003 survey respondents ages 13-55, only three in 10 reported having seen a dermatologist, suggesting that many people with mild-to-moderate acne are missing out on effective treatments.
  • Additionally, 60% of respondents said they "just have to deal with" their acne, and more than half (54%) expressed the opinion that acne is not preventable.
  • "Given the reported lack of control people seem to have over their acne, I find it especially troubling that so few consult a dermatologist.
  • For more information about the cause of acne, skin care tips, videos and more, please visit www.acnehormones.com/derm .

Reversion Clarifying Mask Becomes a 2023 NewBeauty Award Winner

Retrieved on: 
Wednesday, March 29, 2023
Salicylic acid, Skin care, Lactic acid, Breakout box, Skin, Inflammation, Swelling, Blemish, Irritation, Pimple, Red, Reversion, Cosmetics

SPRINGDALE, Ariz., March 29, 2023 /PRNewswire/ -- Therapon Skin Health, the makers of the medical-grade skin care line Theraderm® Clinical Skin Care, is thrilled to receive the 2023 NewBeauty Award for its Reversion Clarifying Mask. Theraderm is dedicated to providing high-quality products that deliver real results. The Reversion Clarifying Mask is a perfect example of this dedication, as it has been named the 'Best Mask for Acne-Prone Skin' by NewBeauty's editors.

Key Points: 
  • SPRINGDALE, Ariz., March 29, 2023 /PRNewswire/ -- Therapon Skin Health, the makers of the medical-grade skin care line Theraderm ® Clinical Skin Care , is thrilled to receive the 2023 NewBeauty Award for its Reversion Clarifying Mask .
  • The Reversion Clarifying Mask is a perfect example of this dedication, as it has been named the 'Best Mask for Acne-Prone Skin' by NewBeauty's editors.
  • The Reversion Clarifying Mask is designed to keep breakouts and excess oiliness under control using the power of kaolin clay, one of the mildest and gentlest clays found in skin care.
  • In addition to kaolin clay, the Clarifying Mask features activated charcoal, salicylic acid, and lactic acid.

The Worldwide Camphor Tablets Industry is Expected to Reach $261 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 31, 2023
Other Natural Resources, Natural Resources, Joint, Moth, Acne, Chemical industry, Food industry, Medication, Swelling, Pain, Athlete, Cooking, Food, Skin, Camphor, Pimple, Agriculture, Congestion, Growth, Tablet, US, Cough, Perfume, Pharmaceutical industry

The Global Camphor Tablets market is expected to reach US$ 261.6 Mn by 2030, growing at a CAGR of 7.6% during the forecast period 2022-2030.

Key Points: 
  • The Global Camphor Tablets market is expected to reach US$ 261.6 Mn by 2030, growing at a CAGR of 7.6% during the forecast period 2022-2030.
  • High consumption of camphor tablets for religious rituals in India is another factor boosting market growth for camphor tablets.
  • Hence, food is also expected to fuel demand for growth of camphor tablets during the forecast period from 2022 to 2030.
  • Therefore growing demand from the medical industry is expected to boost market demand for camphor tablets in 2021.